EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A dual-glycoprotein-targeting bispecific nanoantibody confers potent neutralization against Nipah virus

Shengdong Wang, Xinghai Zhang, Haiwei Zhang, Guibo Rao, Yanfeng Yao, Guihong Tian, Ge Gao, Yun Peng, Wujian Li, Sheng Cao, Sandra Chiu, Rui Gong und 1 weitere

Virologica Sinica · 2026-10 · 41 (5) · 1213-1226

DOI: 10.1016/j.virs.2026.09.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Virologica Sinica, 2026-10. Verfasst von Shengdong Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China; University of Chinese …. Hauptthemen laut MEDLINE: Nipah Virus, Antibodies, Neutralizing, Antibodies, Viral, Henipavirus Infections. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Chinese Academy of Sciences, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nipah virus (NiV) is a biosafety level 4 pathogen that has consistently posed a significant threat to public health. The two envelope proteins on the viral surface, the receptor-binding protein (RBP) and the fusion (F) protein, are the primary targets of neutralizing antibodies. However, the use of antibodies targeting a single viral antigen often leads to the emergence of resistant strains. Here, by panning phage display library, we obtained a C-type nanoantibody (C-Nab), G-3-1, targeting the head domain of RBP. The half-life-extended G-3-1-HLE effectively protected hamsters against authentic NiV challenge. Furthermore, we constructed a fusion protein, 2A1-3-8-(AP)12-G-3-1, by linking G-3-1 to the F-targeting nanobody 2A1-3-8 via a rigid (AP)12 linker. This fusion protein exhibited improved and balanced neutralizing activity. In addition, the in vivo prophylactic efficacy of 2A1-3-8-(AP)12-G-3-1 was validated in a mouse model of NiV pseudovirus infection. Collectively, this study on a dual-envelope-protein-targeting bispecific antibody not only provides a promising antiviral candidate, but also offers an important design strategy for next-generation antibody optimization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nipah VirusAntibodies, NeutralizingAntibodies, ViralHenipavirus InfectionsAntibodies, BispecificViral Envelope ProteinsGlycoproteinsAnimalsMiceCricetinaeRecombinant Fusion ProteinsHumansMice, Inbred BALB CDisease Models, AnimalNeutralization TestsFemale

Stichwörter der Autor:innen

Bispecific nanoantibodiesDual-glycoproteins targetFusion protein (F)Nipah virus (NiV)Receptor binding protein (RBP)Rigid linker

Substanzen

Antibodies, NeutralizingAntibodies, ViralAntibodies, BispecificViral Envelope ProteinsRecombinant Fusion ProteinsGlycoproteins

Autor:innen und Institutionen

  • State Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China; University of Chinese Academy of Sciences, Beijing 100049, China.
  • State Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.
  • Department of Infectious Disease, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230027, China; Division of Life Sciences and Medicine…
  • State Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China. Electronic address: caosheng@wh.iov.cn.
  • State Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China; University of Chinese Academy of Sciences, Beijing 100049, China. Electronic address: gongr@…
  • State Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China. Electronic address: chenli@wh.iov.cn.

Förderung

  • National Natural Science Foundation of China
  • Chinese Academy of Sciences
  • China Postdoctoral Science Foundation

Zitieren

APA

Wang, S., Zhang, X., Zhang, H., Rao, G., Yao, Y., Tian, G., Gao, G., Peng, Y., Li, W., Cao, S., Chiu, S., Gong, R., & Chen, L. (2026). A dual-glycoprotein-targeting bispecific nanoantibody confers potent neutralization against Nipah virus. Virologica Sinica, 41(5), 1213-1226. https://doi.org/10.1016/j.virs.2026.09.014

Vancouver

Wang S, Zhang X, Zhang H, Rao G, Yao Y, Tian G, et al. A dual-glycoprotein-targeting bispecific nanoantibody confers potent neutralization against Nipah virus. Virologica Sinica. 2026;41(5):1213-1226. doi:10.1016/j.virs.2026.09.014

BibTeX
@article{Wang2026,
  author = {Wang, Shengdong and Zhang, Xinghai and Zhang, Haiwei and Rao, Guibo and Yao, Yanfeng and Tian, Guihong and Gao, Ge and Peng, Yun and Li, Wujian and Cao, Sheng and Chiu, Sandra and Gong, Rui and Chen, Li},
  title = {A dual-glycoprotein-targeting bispecific nanoantibody confers potent neutralization against Nipah virus},
  journal = {Virologica Sinica},
  year = {2026},
  volume = {41},
  number = {5},
  pages = {1213--1226},
  doi = {10.1016/j.virs.2026.09.014}
}
Kostenlos starten →